Plenoptika Participates in Spaceflight Vision Testing

By Staff
Monday, December 6, 2021 12:18 AM CAMBRIDGE, Mass.—PlenOptika, creator of the QuickSee handheld autorefractor, announced that is participating in research to understand the impact of spaceflight on vision as part of the Translational Research Institute for Space Health’s (TRISH) research complement.

Biomed Engineering Professor Converts Contact Lenses into Smart Devices to Monitor Glaucoma

By Andrew Karp
Friday, December 3, 2021 8:30 AM New contact lens technology to help diagnose and monitor glaucoma and other ocular health conditions may soon be ready for clinical trials. A team of researchers from Purdue University worked with biomedical, mechanical and chemical engineers, along with clinicians, to develop the novel technology. The team enabled commercial soft contact lenses to be a bioinstrumentation tool for unobtrusive monitoring of clinically important information associated with underlying eye health conditions. “This technology will be greatly beneficial to the painless diagnosis or early detection of many ocular diseases including glaucoma,” said Purdue’s Chi Hwan Lee.

Ophthalmic Medtech Startup OcuDoc Names Grady Lenski as CEO

By Staff
Friday, December 3, 2021 12:30 AM COLUMBUS, Ohio—Columbus-based ophthalmic medtech startup OcuDoc has named veteran optical industry executive Grady Lenski as chief executive officer. In his new role, Lenski will draw on his extensive experience and deep relationships across the industry to help the firm launch and market a mobile autorefractor known as OcuDoc Mobile that is developing. “Grady is a globally-minded optical industry executive with experience in the C-suite, as a board member, and as consultant for several world-class organizations—he’s the perfect leader for the team as it finalizes development and commercial planning,” emphasized OcuDoc board member and optical industry trailblazer, E. Dean Butler.

Prevent Blindness Declares First-Ever Geographic Atrophy Awareness Week as Dec. 6-12, 2021

By Staff
Wednesday, December 1, 2021 12:24 AM CHICAGO—Prevent Blindness is announcing the launch of the first-ever Geographic Atrophy (GA) Awareness Week, to be held Dec. 6-12, 2021.

Evoq Technologies Announces FDA Registration of Smartphone-Based Retinal Health Test Platform

By Staff
Wednesday, December 1, 2021 12:21 AM HENDERSON, Nev.—Evoq, a medical technology startup based here, announced the FDA registration of the first in its family of products based on its proprietary smartphone-based biosensor technology.

VSP Vision Care's New Study Highlights Key Role Eye Exams Play in Improving Outcomes for Patients With Chronic Conditions

By Staff
Monday, November 29, 2021 12:21 AM RANCHO CORDOVA, Calif.—A new study released by VSP Vision Care shows that VSP Vision Care members are “generally healthier and incur fewer health care costs linked to chronic conditions like diabetes and hypertension when compared to members of other vision plans nationwide.”

VM and 20/20 Magazine Announce EyeVote Readers’ Choice Awards for 2021

By Staff
Tuesday, November 23, 2021 12:27 AM NEW YORK—Vision Monday and 20/20 Magazine are pleased to announce the selections in the 13th annual EyeVote Readers’ Choice Awards, a special survey aimed at identifying readers’ favorite products and companies of the year. Optical retailers and ECP readers of the two Jobson Medical Information publications were asked to identify their “favorite” products in 20 distinct categories. Selected companies were chosen based on both brand and company choices supplied by readers. This year’s survey spanned a wide range of product brands and product groups.

CooperVision Launches Student Myopia Leadership Society

By Staff
Tuesday, November 23, 2021 12:18 AM SAN RAMON, Calif.—CooperVision has launched the CooperVision Student Myopia Leadership Society, an initiative that the company said will impact the eyecare profession and patients for decades to come.

The National Center for Children’s Vision and Eye Health at Prevent Blindness Convenes New Children’s Vision Equity Alliance

By Staff
Wednesday, November 17, 2021 12:18 AM CHICAGO—For more than 10 years, The National Center for Children’s Vision and Eye Health at Prevent Blindness (NCCVEH) has worked to ensure that children across the country have equitable access to quality vision and eyecare services.

Prevent Blindness Declares 2nd Annual Thyroid Eye Disease (TED) Awareness Week to Educate the Public on Risk Factors, Symptoms, and Resources for Care

By Staff
Tuesday, November 16, 2021 12:21 AM CHICAGO—Prevent Blindness has declared Nov. 14-20, 2021 as the second annual “Thyroid Eye Disease Awareness (TED) Week.”

FDA Green Lights Clinical Study for Sight Sciences’ Glaucoma Treatment

By Staff
Friday, November 12, 2021 12:27 AM MENLO PARK, Calif.—Sight Sciences (Nasdaq: SGHT) announced on Wednesday that the Food and Drug Administration (FDA) has granted an Investigational Device Exemption (IDE) authorizing the company to conduct a clinical study to assess the safety and effectiveness of a new, higher volume, investigational OMNI device to perform canal viscodilation alone to lower intraocular pressure (IOP) in adults with primary open-angle glaucoma (POAG).

PlenOptika Is Recognized With Prestigious Eddie Award for Innovation

By Staff
Friday, November 12, 2021 12:21 AM CAMBRIDGE, Mass.—PlenOptika, Inc., creator of the QuickSee handheld autorefractor, was recognized with an Eddie Award from Mass Innovation Network.

Alcon Reports 15 Percent Increase in Third Quarter 2021 Sales

By Staff
Thursday, November 11, 2021 12:24 AM GENEVA—Alcon (SIX/NYSE:ALC) reported worldwide sales of $2.1 billion, an increase of 15 percent on a reported basis and 14 percent on a constant currency basis, for the third quarter ended Sept. 30, 2021 versus the same quarter of the previous year, according to an announcement.

TearLab Appoints James Mazzo to Board of Directors Following Recent Restructuring

By Staff
Wednesday, November 10, 2021 12:15 AM SOUTHLAKE, Texas—TearLab Corp., an ophthalmic diagnostics company that develops and markets laboratory point of care technologies that enable ECPs to improve standard of care, has added James V. Mazzo to the company's board of directors.

Alcon Moves to Expand Ophthalmology Portfolio with Bid to Acquire Ivantis and its Hydrus Microstent for Surgical Glaucoma

By Staff
Tuesday, November 9, 2021 12:24 AM GENEVA—Alcon (SIX/NYSE: ALC), a global eyecare company, announced on Monday its intention to acquire Ivantis, developer and manufacturer of the novel Hydrus Microstent, a minimally-invasive glaucoma surgery (MIGS) device designed to lower intraocular pressure for open-angle glaucoma patients in connection with cataract surgery.